BATS BZX Real-Time Price
As of 11:21am ET
| +2.57 / +2.79%|
The 11 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 105.00, with a high estimate of 125.00 and a low estimate of 50.00. The median estimate represents a +10.74% increase from the last price of 94.82.
The current consensus among 13 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.